RUMMELT, Christoph, GRISHINA, Olga, SCHMOOR, Claudia, WÄSCH, Ralph, BECKER, Heiko, MAY, Annette, DUYSTER, Justus, HACKANSON, Björn und LÜBBERT, Michael, 2023. Activity of decitabine combined with all-trans retinoic acid in oligoblastic AML: Results from a randomized 2 x2 phase II trial (DECIDER). Freiburg: Universität.
Elsevier - Harvard (with titles)Rummelt, C., Grishina, O., Schmoor, C., Wäsch, R., Becker, H., May, A., Duyster, J., Hackanson, B., Lübbert, M., 2023. Activity of decitabine combined with all-trans retinoic acid in oligoblastic AML: Results from a randomized 2 x2 phase II trial (DECIDER). Universität, Freiburg. https://doi.org/10.3324/haematol.2022.282258
American Psychological Association 7th editionRummelt, C., Grishina, O., Schmoor, C., Wäsch, R., Becker, H., May, A., Duyster, J., Hackanson, B., & Lübbert, M. (ca. 2023). Activity of decitabine combined with all-trans retinoic acid in oligoblastic AML: Results from a randomized 2 x2 phase II trial (DECIDER) [Cd]. Universität. https://doi.org/10.3324/haematol.2022.282258
Springer - Basic (author-date)Rummelt C, Grishina O, Schmoor C, Wäsch R, Becker H, May A, Duyster J, Hackanson B, Lübbert M (2023) Activity of decitabine combined with all-trans retinoic acid in oligoblastic AML: Results from a randomized 2 x2 phase II trial (DECIDER). Universität, Freiburg
Juristische Zitierweise (Stüber) (Deutsch)Rummelt, Christoph/ Grishina, Olga/ Schmoor, Claudia/ Wäsch, Ralph/ Becker, Heiko/ May, Annette/ Duyster, Justus/ Hackanson, Björn/ Lübbert, Michael, Activity of decitabine combined with all-trans retinoic acid in oligoblastic AML: Results from a randomized 2 x2 phase II trial (DECIDER), Freiburg 2023.